{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:29:47Z","timestamp":1761172187025,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.semerg.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T09:04:53Z","timestamp":1603443893000},"page":"512-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Descripci\u00f3n del uso de medicaci\u00f3n inhalada de rescate en una poblaci\u00f3n asm\u00e1tica atendida en el \u00e1mbito de Atenci\u00f3n Primaria. Estudio UMI-ASMA"],"prefix":"10.1016","volume":"46","author":[{"given":"R.","family":"de Sim\u00f3n Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Quijada Monz\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Ortiz Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2020.07.009_bib0210","unstructured":"Encuesta Nacional de Salud de Espa\u00f1a 2017. Madrid: Ministerio de Sanidad, Consumo y Bienestar Social; 2017. [Internet]. [consultado 3 Dic 2018]. Disponible en: https:\/\/www.mscbs.gob.es\/estadEstudios\/estadisticas\/encuestaNacional\/encuestaNac2017\/encuestaResDetall2017.htm"},{"key":"10.1016\/j.semerg.2020.07.009_bib0215","first-page":"761","article-title":"Estudio Europeo del Asma. Prevalencia de hiperreactividad bronquial y asma en adultos j\u00f3venes de cinco \u00e1reas espa\u00f1olas","volume":"106","year":"1996","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.semerg.2020.07.009_bib0220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.semerg.2019.02.014","article-title":"Mortalidad por asma en Espa\u00f1a, 1990-2015","volume":"45","author":"G\u00f3mez S\u00e1enz","year":"2019","journal-title":"Semergen."},{"key":"10.1016\/j.semerg.2020.07.009_bib0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semerg.2018.01.011","article-title":"Persistencia al tratamiento y uso de recursos con corticosteroides y agonistas \u03b2-adren\u00e9rgicos de larga duraci\u00f3n inhalados a dosis fijas para el tratamiento del asma: estudio retrospectivo de base poblacional","volume":"44","author":"Sicras-Mainar","year":"2018","journal-title":"Semergen."},{"key":"10.1016\/j.semerg.2020.07.009_bib0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1183\/09031936.00155307","article-title":"A new perspective on concepts of asthma severity and control","volume":"32","author":"Taylor","year":"2008","journal-title":"Eur Respir J."},{"key":"10.1016\/j.semerg.2020.07.009_bib0235","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0091-6749(96)80185-0","article-title":"Asthma control versus asthma severity","volume":"98","author":"Cockcroft","year":"1996","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0240","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.aprim.2016.12.005","article-title":"Control del asma en pacientes que acuden a consulta de atenci\u00f3n primaria en Espa\u00f1a (estudio ACTIS)","volume":"49","author":"Calvo","year":"2017","journal-title":"Aten Primaria."},{"issue":"Supl 1","key":"10.1016\/j.semerg.2020.07.009_bib0245","first-page":"29","article-title":"Resultados estudio ESCASE. Estudio control del asma en Espa\u00f1a","volume":"9","author":"Ruiz Cobos","year":"2006","journal-title":"Rev Patol Respir."},{"key":"10.1016\/j.semerg.2020.07.009_bib0250","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/02770900802216783","article-title":"Control of persistent asthma in Spain: Associated factors","volume":"45","author":"De Miguel D\u00edez","year":"2008","journal-title":"J Asthma."},{"issue":"Supl 1","key":"10.1016\/j.semerg.2020.07.009_bib0255","first-page":"35","article-title":"Causas de asma de control dif\u00edcil (ACD). Factores que pueden agravar el asma","volume":"62","author":"Navarro Merino","year":"2005","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.semerg.2020.07.009_bib0260","unstructured":"GEMA 5.0. Gu\u00eda Espa\u00f1ola para el Manejo del Asma. 2020. [Internet]. [consultado 1 Jun 2020]. Disponible en: https:\/\/www.gemasma.com\/"},{"key":"10.1016\/j.semerg.2020.07.009_bib0265","unstructured":"GINA 2018. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI\/WHO Workshop Report. [Internet]. [consultado 8 Dic 2018]. Disponible en: http:\/\/www.ginasthma.com"},{"key":"10.1016\/j.semerg.2020.07.009_bib0270","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1378\/chest.119.4.1011","article-title":"Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up","volume":"119","author":"Belda","year":"2001","journal-title":"Chest."},{"key":"10.1016\/j.semerg.2020.07.009_bib0275","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2011.06.008","article-title":"Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids","volume":"128","author":"Zeiger","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: A survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0285","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.clinthera.2008.10.005","article-title":"Validation of the Spanish version of the Asthma Control Questionnaire","volume":"30","author":"Picado","year":"2008","journal-title":"Clin Ther."},{"key":"10.1016\/j.semerg.2020.07.009_bib0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.anai.2015.03.002","article-title":"Factors associated with high short-acting \u03b22-agonist use in urban children with asthma","volume":"114","author":"Butz","year":"2015","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0295","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaip.2013.04.008","article-title":"Short-acting \u03b2-agonist use as a marker of current asthma control","volume":"1","author":"Patel","year":"2013","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"3 Pt 1","key":"10.1016\/j.semerg.2020.07.009_bib0300","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/ajrccm.149.3.8118625","article-title":"A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists","volume":"149","author":"Suissa","year":"1994","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.semerg.2020.07.009_bib0305","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/cea.12166","article-title":"Metrics of salbutamol use as predictors of future adverse outcomes in asthma","volume":"43","author":"Patel","year":"2013","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.semerg.2020.07.009_bib0310","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Definition and general considerations. [Internet]. [consultado 10 Dic 2018]. Disponible en: https:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/"},{"key":"10.1016\/j.semerg.2020.07.009_bib0315","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: Optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.semerg.2020.07.009_bib0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12890-018-0598-4","article-title":"Predictors of inappropriate and excessive use of reliever medications in asthma: A 16-year population-based study","volume":"18","author":"Tavakoli","year":"2018","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.semerg.2020.07.009_bib0325","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.sapharm.2005.07.001","article-title":"Pharmacy-specific quality indicators for asthma therapy","volume":"1","author":"Winterstein","year":"2005","journal-title":"Res Social Adm Pharm."},{"key":"10.1016\/j.semerg.2020.07.009_bib0330","doi-asserted-by":"crossref","unstructured":"Levy ML. The national review of asthma deaths: \u00bfwhat did we learn and what needs to change? Breathe (Sheff). 2015;11(1):14-24. doi:10.1183\/20734735.008914","DOI":"10.1183\/20734735.008914"},{"key":"10.1016\/j.semerg.2020.07.009_bib0335","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thorax.57.8.683","article-title":"Respiratory medications and risk of asthma death","volume":"57","author":"Lanes","year":"2002","journal-title":"Thorax."},{"key":"10.1016\/j.semerg.2020.07.009_bib0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.08.014","article-title":"The impact of inappropriate use of short acting beta agonists in asthma","volume":"131","author":"FitzGerald","year":"2017","journal-title":"Respir Med."},{"key":"10.1016\/j.semerg.2020.07.009_bib0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41533-018-0096-4","article-title":"\u201cTossing a coin:\u201d Defining the excessive use of short-acting beta2-agonists in asthma--The views of general practitioners and asthma experts in primary and secondary care","volume":"28","author":"McKibben","year":"2018","journal-title":"NPJ Prim Care Respir Med."},{"key":"10.1016\/j.semerg.2020.07.009_bib0350","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arbres.2014.03.002","article-title":"Factores asociados con el asma grave no controlada y con la percepci\u00f3n del control por parte de m\u00e9dicos y pacientes","volume":"50","author":"Vennera","year":"2014","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semerg.2017.03.005","article-title":"Uso de recursos y costes asociados a la no adherencia al tratamiento con corticoides inhalados en el asma","volume":"44","author":"Sicras-Mainar","year":"2018","journal-title":"Semergen."},{"key":"10.1016\/j.semerg.2020.07.009_bib0360","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2018.11.001","article-title":"Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice","volume":"146","author":"Baldacci","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.semerg.2020.07.009_bib0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)63001-3","article-title":"Nonadherence in asthmatic patients: Is there a solution to the problem?","volume":"793","author":"Bender","year":"1997","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0370","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4187\/respcare.03200","article-title":"Asthma and adherence to inhaled corticosteroids: Current status and future perspectives","volume":"60","author":"Barnes","year":"2015","journal-title":"Respir Care."},{"key":"10.1016\/j.semerg.2020.07.009_bib0375","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaip.2016.05.019","article-title":"What we mean when we talk about adherence in respiratory medicine","volume":"4","author":"Vrijens","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.semerg.2020.07.009_bib0380","first-page":"13","article-title":"Adherencia al tratamiento en asma. Situaci\u00f3n actual","volume":"2","author":"Melero Moreno","year":"2017","journal-title":"Rev Asma."},{"key":"10.1016\/j.semerg.2020.07.009_bib0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.18176\/jiaci.0387","article-title":"Clinical factors associated with overuse of asthma reliever medication","volume":"30","author":"Urrutia","year":"2020","journal-title":"J Investig Allergol Clin Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41533-018-0103-9","article-title":"Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations","volume":"28","author":"Yang","year":"2018","journal-title":"NPJ Prim Care Respir Med."},{"key":"10.1016\/j.semerg.2020.07.009_bib0395","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00130832-200502000-00011","article-title":"The influence of smoking on the treatment response in patients with asthma","volume":"5","author":"Thomson","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"10.1016\/j.semerg.2020.07.009_bib0400","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.121.5.1407","article-title":"Near-fatal asthma: A population-based study of risk factors","volume":"121","author":"Mitchell","year":"2002","journal-title":"Chest."},{"key":"10.1016\/j.semerg.2020.07.009_bib0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1157\/13071913","article-title":"Prevalencia del tabaquismo y prevenci\u00f3n en pacientes con asma persistente","volume":"35","author":"Monz\u00f3n Ballar\u00edn","year":"2005","journal-title":"Aten Primaria."},{"key":"10.1016\/j.semerg.2020.07.009_bib0410","unstructured":"Federaci\u00f3n Empresarial de Farmac\u00e9uticos Espa\u00f1oles. Observatorio del medicamento. Madrid: FEFE; 2019. [Internet]. [consultado 13 Ago 2019]. Disponible en: http:\/\/fefe.com\/category\/observatorio-medicamento\/"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320303208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320303208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:40:36Z","timestamp":1761108036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359320303208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1138359320303208"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2020.07.009","relation":{},"ISSN":["1138-3593"],"issn-type":[{"type":"print","value":"1138-3593"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Descripci\u00f3n del uso de medicaci\u00f3n inhalada de rescate en una poblaci\u00f3n asm\u00e1tica atendida en el \u00e1mbito de Atenci\u00f3n Primaria. Estudio UMI-ASMA","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}